Skip to Content
You are currently on the new version of our website. Access the old version .
Current OncologyCurrent Oncology
  • Case Report
  • Open Access

1 December 2024

6 Pages

Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy for Non-Small Cell Lung Cancer Using Varian Ethos Therapy System

,
,
,
,
,
,
,
,
…
1
Specialty Hospital Radiochirurgia Zagreb, 10431 Sveta Nedelja, Croatia
2
Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia
3
School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
4
Faculty of Medicine, Juraj Dobrila University of Pula, 52100 Pula, Croatia
This article belongs to the Topic Innovative Radiation Therapies

Abstract

We present a patient treated with personalized ultra-fractionated stereotactic adaptive radiotherapy (PULSAR) for non-small cell lung cancer (NSCLC) using the adaptive Varian Ethos™ system equipped with the novel HyperSight imaging platform. Three pulses of 12 Gy were separated by a pause of four weeks during which the tumor was given enough time to respond to treatment. Only initial planning computed tomography (CT) was acquired on a CT simulator (Siemens Somatom Definition Edge), whereas other pulses were adapted using online cone beam computed tomography (CBCT) images (iCBCT Acuros reconstruction) acquired while the patient was lying on the treatment couch and delivered immediately. Significant tumor reduction was achieved between pulses, resulting in improved organs-at-risk sparing. In addition, the on-couch plan optimization based on CBCT greatly reduced the patient’s stay at the clinic and the duration of treatment preparation.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.